CIK 0001503802
- Non-accelerated filer
- Smaller reporting company
Karyopharm Therapeutics Inc.
Sign in to watch- Tickers
- KPTI KPTIQ
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 263931704
- Phone
- +1 617-658-0600
- Business address
- 85 WELLS AVENUE, SECOND FLOOR, NEWTON, MA, 02459
Securities
- KPTI Common stock Nasdaq
- KPTIQ Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,135
- in 3 filings
Net −$2,135. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-06-15 | Shacham Sharon President & CSO | Exercise or conversion · Stock Option (right to buy) | −7,143 | 16,424 | ||
| 2020-06-15 | Shacham Sharon President & CSO | Exercise or conversion · Stock Option (right to buy) | −357 | 0 | ||
| 2020-06-10 | Kauffman Michael Chief Executive Officer | Exercise or conversion | +7,500 | $4.75 | $36K | 562,622 |
| 2020-06-10 | Kauffman Michael Chief Executive Officer | Sale | −7,500 | $18.13 | $136K | 555,122 |
| 2020-06-10 | Kauffman Michael Chief Executive Officer | Exercise or conversion · Stock Option (right to buy) | −7,500 | 341,061 | ||
| 2020-06-10 | Shacham Sharon President & CSO | Exercise or conversion | +7,500 | $4.75 | $36K | 562,622 |
| 2020-06-10 | Shacham Sharon President & CSO | Sale | −7,500 | $18.13 | $136K | 555,122 |
| 2020-06-10 | Shacham Sharon President & CSO | Exercise or conversion · Stock Option (right to buy) | −7,500 | 341,061 | ||
| 2020-06-09 | Kauffman Michael Chief Executive Officer | Exercise or conversion | +7,500 | $4.75 | $36K | 763,989 |
| 2020-06-09 | Kauffman Michael Chief Executive Officer | Sale | −7,500 | $18.50 | $139K | 756,489 |
| 2020-06-09 | Kauffman Michael Chief Executive Officer | Exercise or conversion · Stock Option (right to buy) | −7,500 | 385,303 | ||
| 2020-06-09 | Shacham Sharon President & CSO | Exercise or conversion | +7,500 | $4.75 | $36K | 763,989 |
| 2020-06-09 | Shacham Sharon President & CSO | Sale | −7,500 | $18.50 | $139K | 756,489 |
| 2020-06-09 | Shacham Sharon President & CSO | Exercise or conversion · Stock Option (right to buy) | −7,500 | 385,303 | ||
| 2020-05-21 | Paulson Richard A. Director | Grant or award · Nonstatutory Stock Option (right to buy) | +16,400 | 16,400 | ||
| 2020-05-21 | PAKIANATHAN DEEPIKA Director | Grant or award · Nonstatutory Stock Option (right to buy) | +16,400 | 16,400 | ||
| 2020-05-21 | Mirza Mansoor Raza Director | Grant or award · Nonstatutory Stock Option (right to buy) | +16,400 | 16,400 | ||
| 2020-05-21 | Greene Barry E Director | Grant or award · Nonstatutory Stock Option (right to buy) | +16,400 | 16,400 | ||
| 2020-05-21 | Dolsten Mikael Director | Grant or award · Nonstatutory Stock Option (right to buy) | +16,400 | 16,400 | ||
| 2020-05-21 | BOHLIN GAREN G Director | Grant or award · Nonstatutory Stock Option (right to buy) | +16,400 | 16,400 |
Page 24 of 29 · 570 trades